Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis.

about

Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q38772800

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Influence of comorbidity on ch ...... atic review and meta-analysis.

@en

type

Item

label

Influence of comorbidity on ch ...... atic review and meta-analysis.

@en

prefLabel

Influence of comorbidity on ch ...... atic review and meta-analysis.

@en

P1476

Influence of comorbidity on ch ...... matic review and meta-analysis

@en

P2093

Ian D Campbell

http://www.w3.org/2001/XMLSchema#string

Marion J Kuper-Hommel

http://www.w3.org/2001/XMLSchema#string

Ross A Lawrenson

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2012

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial.

Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy.

Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study.

Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).

Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.

Racial variation in breast cancer treatment among Department of Defense beneficiaries.

P2888

s10549-017-4295-4

P304

17-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S10549-017-4295-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P50

Melissa Edwards

P577

2017-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085451019

http://www.w3.org/2001/XMLSchema#string

P698

28528451

http://www.w3.org/2001/XMLSchema#string